One Company is Changing the Way We Think About Treating Illness With Advanced Processing Technology
Here at Dover we believe that innovation is the fuel for progress. One company that aims to redefine the limits of IoT is Nano Global. Established in 2015 by Steve Papermaster, Nano was founded with the mission to “use technology to collect and analyze real-time molecular data to fight global health threats.” The company hopes to utilize cutting edge tech to reduce the loss of life and economic impact from cancers and infectious diseases.
The Austin based company recently announced a partnership with ARM to produce a SoC which will work to capture and analyze molecular data in real time. The joint SoC will be coupled with Nano’s proprietary scientific technology platform to make data available to researchers across the globe. The AI chip will also integrate advances in nanotechnology, optics, and blockchain authentication.
Molecular identification is made possible by leveraging AI to determine different types of molecular structures as they occur in our environment. This technology works on the same principle as facial recognition. Millions of different data points are collected about these structures enabling researchers to identify and study them.
Nano also hopes to create a marketplace for this data so it can be shared and sold between researchers. These blockchain secured transactions will aid in the research and development of new drugs and treatments for diseases. This molecular data could become incredibly valuable as current drug development relies on proprietary research carried out by independent laboratories.
Beyond merely developing the AI SoC with ARM, Nano has plans to partner with manufacturers to integrate their technology into a wide variety of devices from cell phones to watches. The ultimate vision is integrating the SoCs into objects such as bandages which could then detect pathogens and release drugs into the patient. Paperman states, “The data our technology can acquire and process will enable us to create safer and healthier world.” With the first delivery expected for 2020, we could see this technology’s impact in as little as 4 years. In the future we hope to see more companies harness advanced processing technology to further medical outcomes.